Ocular Therapeutix Inc Forecast, price target & analysts
Ocular Therapeutix Inc Target price 2025 - Analyst rating & recommendation
Ocular Therapeutix Inc Classifications & Recommendation:
Ocular Therapeutix Inc Price Target
| Target Price | $17.62 |
| Price | $7.17 |
| Potential |
145.68%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Ocular Therapeutix Inc 2026 .
The average Ocular Therapeutix Inc target price is $17.62.
This is
145.68%
register free of charge
$22.00
206.83%
register free of charge
$14.00
95.26%
register free of charge
|
|
| A rating was issued by 13 analysts: 13 Analysts recommend Ocular Therapeutix Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ocular Therapeutix Inc stock has an average upside potential 2026 of
145.68%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 63.72 | 70.78 |
| 9.03% | 11.08% | |
| EBITDA Margin | -263.65% | -295.99% |
| 94.05% | 12.26% | |
| Net Margin | -302.03% | -270.21% |
| 9.70% | 10.54% |
13 Analysts have issued a sales forecast Ocular Therapeutix Inc 2025 . The average Ocular Therapeutix Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Ocular Therapeutix Inc EBITDA forecast 2025. The average Ocular Therapeutix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Ocular Therapeutix Inc Analysts have issued a net profit forecast 2025. The average Ocular Therapeutix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.22 | -1.21 |
| 19.61% | 0.82% | |
| P/E | negative | |
| EV/Sales | 12.45 |
13 Analysts have issued a Ocular Therapeutix Inc forecast for earnings per share. The average Ocular Therapeutix Inc EPS is
This results in the following potential growth metrics and future valuations:
Ocular Therapeutix Inc...
Current Ocular Therapeutix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| William Blair |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 03 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
William Blair:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 03 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
